Literature DB >> 19261349

A "live" biopsy in a small-cell lung cancer patient by detection of circulating tumor cells.

Simona Bevilacqua1, Marianna Gallo, Renato Franco, Antonio Rossi, Antonella De Luca, Gaetano Rocco, Gerardo Botti, Cesare Gridelli, Nicola Normanno.   

Abstract

A 71-year-old patient with a pulmonary lesion was diagnosed with a low-grade neuroendocrine tumor following examination of a fine needle aspiration biopsy. Analysis of a peripheral blood sample with the CellSearch system revealed the presence of putative circulating tumor cells (CTC) that were positive for EpCAM and cytokeratin (CK) expression. Since EpCAM is not usually expressed in neuroendocrine tumors, we performed a biopsy of liver metastases. Morphological and immunophenotypical characterization revealed that the patient had an EpCAM and CK positive small-cell lung cancer (SCLC). By using the CellSearch apparatus, EpCAM/CK positive CTC were detected in peripheral blood samples from 3 out of 4 additional SCLC patients. This study is the first to demonstrate that CTC can be identified in SCLC patients by using the CellSearch system.

Entities:  

Mesh:

Year:  2009        PMID: 19261349     DOI: 10.1016/j.lungcan.2009.01.019

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  12 in total

Review 1.  Circulating tumor cells versus circulating tumor DNA in lung cancer-which one will win?

Authors:  Silvia Calabuig-Fariñas; Eloísa Jantus-Lewintre; Alejandro Herreros-Pomares; Carlos Camps
Journal:  Transl Lung Cancer Res       Date:  2016-10

2.  A preliminary study on the relationship between circulating tumor cells count and clinical features in patients with non-small cell lung cancer.

Authors:  Jia-Wei Wan; Ming-Zhu Gao; Rong-Jun Hu; Hong-Yu Huang; Yu-Yun Wei; Zhi-Jun Han; Zi-He Yan
Journal:  Ann Transl Med       Date:  2015-12

3.  Genomic and Functional Fidelity of Small Cell Lung Cancer Patient-Derived Xenografts.

Authors:  Benjamin J Drapkin; Julie George; Camilla L Christensen; Mari Mino-Kenudson; Ruben Dries; Tilak Sundaresan; Sarah Phat; David T Myers; Jun Zhong; Peter Igo; Mehlika H Hazar-Rethinam; Joseph A Licausi; Maria Gomez-Caraballo; Marina Kem; Kandarp N Jani; Roxana Azimi; Nima Abedpour; Roopika Menon; Sotirios Lakis; Rebecca S Heist; Reinhard Büttner; Stefan Haas; Lecia V Sequist; Alice T Shaw; Kwok-Kin Wong; Aaron N Hata; Mehmet Toner; Shyamala Maheswaran; Daniel A Haber; Martin Peifer; Nicholas Dyson; Roman K Thomas; Anna F Farago
Journal:  Cancer Discov       Date:  2018-02-26       Impact factor: 39.397

Review 4.  Promising Role of Circulating Tumor Cells in the Management of SCLC.

Authors:  Antonella De Luca; Marianna Gallo; Claudia Esposito; Alessandro Morabito; Nicola Normanno
Journal:  Cancers (Basel)       Date:  2021-04-22       Impact factor: 6.639

Review 5.  Clinical Applications of Circulating Tumor Cells in Lung Cancer Patients by CellSearch System.

Authors:  Anna Truini; Angela Alama; Maria Giovanna Dal Bello; Simona Coco; Irene Vanni; Erika Rijavec; Carlo Genova; Giulia Barletta; Federica Biello; Francesco Grossi
Journal:  Front Oncol       Date:  2014-09-04       Impact factor: 6.244

Review 6.  Molecular characterization of circulating tumor cells in lung cancer: moving beyond enumeration.

Authors:  Lei Wang; Coraline Dumenil; Catherine Julié; Violaine Giraud; Jennifer Dumoulin; Sylvie Labrune; Thierry Chinet; Jean-François Emile; Biao He; Etienne Giroux Leprieur
Journal:  Oncotarget       Date:  2017-11-23

7.  Prognostic and predictive value of circulating tumor cells and CXCR4 expression as biomarkers for a CXCR4 peptide antagonist in combination with carboplatin-etoposide in small cell lung cancer: exploratory analysis of a phase II study.

Authors:  Ravi Salgia; R Waide Weaver; Michael McCleod; John R Stille; S Betty Yan; Stephanie Roberson; John Polzer; Amy Flynt; Eyas Raddad; Victoria L Peek; Sameera R Wijayawardana; Suzane L Um; Steve Gross; Mark C Connelly; Carrie Morano; Madeline Repollet; Renouard Sanders; Kurt Baeten; David D'Haese; David R Spigel
Journal:  Invest New Drugs       Date:  2017-03-15       Impact factor: 3.850

Review 8.  [Advance of circulating tumor cell in patients with lung cancer].

Authors:  Wei Ping; Xiangning Fu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2011-06

Review 9.  [Advances in research on circulating tumor cells in lung cancer].

Authors:  Yingjian Song; Zheng Wang; Lin Yang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2012-10

Review 10.  [Advanced research on circulating tumor cells in lung cancer].

Authors:  Hui Li; Hongxia Cui; Ying Cheng
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2012-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.